Yoojin Jung, NP

Yoojin Jung practices at Surgery Center Palo Alto in Palo Alto, California.

Yoojin Jung's NPI, 1780152165, was assigned on November 5, 2018. Yoojin Jung holds California license NP95016376.

Yoojin Jung's primary practice is Surgery Center Palo Alto, at 795 El Camino Real, Palo Alto, CA 94301. The practice phone is (650) 324-1832.

Yoojin Jung's primary practice is Surgery Center Palo Alto in Palo Alto, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Yoojin Jung to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yoojin Jung practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Yoojin Jung's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Dmand AI has Yoojin Jung's licenses on file in 2 states: California and New York.

Dmand AI lists chronic diabetes, drug use disorders, ear infection, fibromyalgia and chronic pain, high cholesterol, muscle pain, fibromyalgia, and limb pain, underactive thyroid and vitamin d deficiency among the conditions Yoojin Jung treats.

CMS data shows 188 Medicare services from Yoojin Jung across 4 procedure codes in 2024, all of them office visits, for 179 Medicare patients. Medicare paid $14,194 for them. Every service was in an office.

CMS counts 179 Medicare patients who saw Yoojin Jung in 2024. The largest group is 65 to 74, with 82 patients. 68% of them have high cholesterol, and 58% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Yoojin Jung's median patient age at 50, with 59% women.

In 2024, Yoojin Jung wrote 220 Medicare Part D claims for 142 patients. 86% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each.

Yoojin Jung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Yoojin Jung as offering telehealth.

CMS Open Payments shows 2 general payments to Yoojin Jung from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $150.